Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986. Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505. Case and Commentary Oct 2009 The Patient Who Says He Is Ready to Die Margaret Tarpley, MLS and John Tarpley, MD Virtual Mentor. 2009;11(10):761-765. doi: 10.1001/virtualmentor.2009.11.10.ccas3-0910. Case and Commentary Oct 2008 Physician and Parental Decision Making in Newborn Resuscitation, Commentary 2 Frank A. Chervenak, MD and Laurence B. McCullough, PhD Virtual Mentor. 2008;10(10):620-624. doi: 10.1001/virtualmentor.2008.10.10.ccas1-0810. Medicine and Society Feb 2009 The Double Helix and Double-Edged Sword: How the Public Thinks about Genes Jason Schnittker, PhD Virtual Mentor. 2009;11(2):155-160. doi: 10.1001/virtualmentor.2009.11.2.msoc1-0902. Policy Forum Oct 2004 Should Surgery Have an FDA? Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):459-461. doi: 10.1001/virtualmentor.2004.6.10.pfor2-0410. In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102. Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404. In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo When adolescents seek emergency contraception in the emergency room, social judgment on the part of clinicians can hamper treatment. Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986.
Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105.
In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505.
Case and Commentary Oct 2009 The Patient Who Says He Is Ready to Die Margaret Tarpley, MLS and John Tarpley, MD Virtual Mentor. 2009;11(10):761-765. doi: 10.1001/virtualmentor.2009.11.10.ccas3-0910.
Case and Commentary Oct 2008 Physician and Parental Decision Making in Newborn Resuscitation, Commentary 2 Frank A. Chervenak, MD and Laurence B. McCullough, PhD Virtual Mentor. 2008;10(10):620-624. doi: 10.1001/virtualmentor.2008.10.10.ccas1-0810.
Medicine and Society Feb 2009 The Double Helix and Double-Edged Sword: How the Public Thinks about Genes Jason Schnittker, PhD Virtual Mentor. 2009;11(2):155-160. doi: 10.1001/virtualmentor.2009.11.2.msoc1-0902.
Policy Forum Oct 2004 Should Surgery Have an FDA? Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):459-461. doi: 10.1001/virtualmentor.2004.6.10.pfor2-0410.
In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102.
Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.
In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo When adolescents seek emergency contraception in the emergency room, social judgment on the part of clinicians can hamper treatment. Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202.